Amalgamated Financial’s Immunic IMUX Stock Holding History

Amalgamated Financial’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$26K	Buy	+226	New	+$26.2K	﹤0.01%	2660

Other funds holding IMUX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Amalgamated Financial's IMUX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Immunic (IMUX) in Q1 2022: 226 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #2660 among its holdings.

80 funds tracked by Wall St. Rank hold IMUX as of Q1 2022.

Amalgamated Financial held 226 shares of Immunic worth $26K as of Q1 2022.
Immunic was a new Amalgamated Financial position in Q1 2022.
Immunic made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2660 holding.
80 funds tracked by Wall St. Rank held Immunic as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.